Literature DB >> 111699

ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. II. Investigation into the mechanism of lysis.

S J Urbaniak.   

Abstract

The mechanism of lysis of anti-D coated human erythrocytes by human mononuclear K-cells was investigated. Red cell lysis was measurable after 30 min incubation and reached a maximum by 18--20 h. Cell-to-cell contact was necessary for lysis, phagocytosis was not a prerequisite, and intact microfilament function was required. The divalent cations Ca2+ and Mg2+ were both required for lysis to occur. Studies with metabolic inhibitors indicate that some RNA and protein synthesis is required for maximum expression of ADCC and intact microtubule function is essential. In the present system lysis was mediated by IgG1 anti-D antibodies and was significantly inhibited by IgG1 and IgG3 subclasses with some inhibition by IgG2 but not by IgG4, IgA or IgM. This suggests that the K-cell receptor is specific for IgG but that there is major cross-reactivity between IgG1 and IgG3. The inhibiting effect of hydrocortisone suggests that ADCC inhibition may be one mode of action of corticosteroids in ameliorating autoimmune haemolytic anaemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111699     DOI: 10.1111/j.1365-2141.1979.tb01135.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Intravenous immunoglobulins in rhesus hemolytic disease.

Authors:  Kanya Mukhopadhyay; Srinivas Murki; Anil Narang; Sourabh Dutta
Journal:  Indian J Pediatr       Date:  2003-09       Impact factor: 1.967

Review 2.  Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.

Authors:  R Gottstein; R W I Cooke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

3.  Intravenous Immunoglobulin G Treatment in ABO Hemolytic Disease of the Newborn, is it Myth or Real?

Authors:  Serdar Beken; Ibrahim Hirfanoglu; Canan Turkyilmaz; Nilgun Altuntas; Sezin Unal; Ozden Turan; Esra Onal; Ebru Ergenekon; Esin Koc; Yildiz Atalay
Journal:  Indian J Hematol Blood Transfus       Date:  2012-08-28       Impact factor: 0.900

4.  Destruction of IgG anti-A sensitized erythrocytes by mononuclear leucocytes from normal and ABO haemolytic disease affected infants.

Authors:  E L Romano; M L Rossi Devivo; A Soyano; J Linares
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

5.  Rh isoimmunized pregnancy managed noninvasively: A report of two cases.

Authors:  Deepti Jain
Journal:  Int J Appl Basic Med Res       Date:  2017 Jan-Mar

Review 6.  Immunoglobulin for alloimmune hemolytic disease in neonates.

Authors:  Carolien Zwiers; Mirjam Ea Scheffer-Rath; Enrico Lopriore; Masja de Haas; Helen G Liley
Journal:  Cochrane Database Syst Rev       Date:  2018-03-18

7.  Anti-RhD antibody therapy modulates human natural killer cell function.

Authors:  Shlomo Elias; Inbal Kol; Shira Kahlon; Rajaa Amore; Mariam Zeibak; Dror Mevorach; Uriel Elchalal; Orly Zelig; Ofer Mandelboim
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.